These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. Aspenberg P. J Orthop Res; 2004 May; 22(3):684; author reply 685. PubMed ID: 15099653 [No Abstract] [Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Vuolteenaho K, Moilanen T, Moilanen E. Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900 [Abstract] [Full Text] [Related]
4. Negative effect of parecoxib on bone mineral during fracture healing in rats. Dimmen S, Nordsletten L, Engebretsen L, Steen H, Madsen JE. Acta Orthop; 2008 Jun; 79(3):438-44. PubMed ID: 18626809 [Abstract] [Full Text] [Related]
5. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, Cullinane DM, Krall EA, Fitch JL, Webb EG, Thiede MA, Einhorn TA. J Bone Joint Surg Am; 2007 Jan; 89(1):114-25. PubMed ID: 17200318 [Abstract] [Full Text] [Related]
6. Cyclo-oxygenase 2 function is essential for bone fracture healing. Simon AM, Manigrasso MB, O'Connor JP. J Bone Miner Res; 2002 Jun; 17(6):963-76. PubMed ID: 12054171 [Abstract] [Full Text] [Related]
7. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Cappon GD, Cook JC, Hurtt ME. Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):47-56. PubMed ID: 12852483 [Abstract] [Full Text] [Related]
8. Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib. Urdaneta A, Siso A, Urdaneta B, Cardenas R, Quintero L, Avila R, Suarez-Roca H. Brain Res Bull; 2009 Aug 28; 80(1-2):56-61. PubMed ID: 19463915 [Abstract] [Full Text] [Related]
9. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Muscará MN, McKnight W, Asfaha S, Wallace JL. Br J Pharmacol; 2000 Feb 28; 129(4):681-6. PubMed ID: 10683192 [Abstract] [Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation. Hsueh SF, Lu CY, Chao CS, Tan PH, Huang YW, Hsieh SW, Hsiao HT, Chung NC, Lin SH, Huang PL, Lyu PC, Yang LC. Brain Res Mol Brain Res; 2004 Jun 18; 125(1-2):113-9. PubMed ID: 15193428 [Abstract] [Full Text] [Related]
11. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, Sun T, O'Yang C, Hunter JC, Eglen RM, Johnson RM. J Pharmacol Exp Ther; 1999 Mar 18; 288(3):1288-97. PubMed ID: 10027870 [Abstract] [Full Text] [Related]
12. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Waterbury LD, Silliman D, Jolas T. Curr Med Res Opin; 2006 Jun 18; 22(6):1133-40. PubMed ID: 16846546 [Abstract] [Full Text] [Related]
13. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ, Koboldt CM, Muhammad JL, Zweifel BS, Masferrer JL, Isakson PC, Seibert K. J Pharmacol Exp Ther; 2005 Mar 18; 312(3):1206-12. PubMed ID: 15494548 [Abstract] [Full Text] [Related]
14. Clinical pharmacology of selective COX-2 inhibitors. Capone ML, Tacconelli S, Sciulli MG, Patrignani P. Int J Immunopathol Pharmacol; 2003 Mar 18; 16(2 Suppl):49-58. PubMed ID: 14552704 [Abstract] [Full Text] [Related]
16. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient]. Galli G, Panzetta G. G Ital Nefrol; 2002 Apr 26; 19(2):199-203. PubMed ID: 12195419 [Abstract] [Full Text] [Related]
17. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Chen XH, Bai JY, Shen F, Bai AP, Guo ZR, Cheng GF. Acta Pharmacol Sin; 2004 Jul 26; 25(7):927-31. PubMed ID: 15210067 [Abstract] [Full Text] [Related]
18. COX-2 selective NSAID decreases bone ingrowth in vivo. Goodman S, Ma T, Trindade M, Ikenoue T, Matsuura I, Wong N, Fox N, Genovese M, Regula D, Smith RL. J Orthop Res; 2002 Nov 26; 20(6):1164-9. PubMed ID: 12472224 [Abstract] [Full Text] [Related]
19. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. Simon AM, O'Connor JP. J Bone Joint Surg Am; 2007 Mar 26; 89(3):500-11. PubMed ID: 17332098 [Abstract] [Full Text] [Related]
20. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG. Bone; 2008 Oct 26; 43(4):653-62. PubMed ID: 18582604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]